AR094196A1 - Composicion para el cuidado oral, kit, metodo de fabricacion - Google Patents

Composicion para el cuidado oral, kit, metodo de fabricacion

Info

Publication number
AR094196A1
AR094196A1 ARP130104929A ARP130104929A AR094196A1 AR 094196 A1 AR094196 A1 AR 094196A1 AR P130104929 A ARP130104929 A AR P130104929A AR P130104929 A ARP130104929 A AR P130104929A AR 094196 A1 AR094196 A1 AR 094196A1
Authority
AR
Argentina
Prior art keywords
composition
zinc
ascorbyl
phosphate
oral care
Prior art date
Application number
ARP130104929A
Other languages
English (en)
Spanish (es)
Inventor
Hao Zhigang
Yang Ying
Liu Zhiqiang
Xu Guofeng
J Vincenti Paul
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of AR094196A1 publication Critical patent/AR094196A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP130104929A 2012-12-19 2013-12-19 Composicion para el cuidado oral, kit, metodo de fabricacion AR094196A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/070497 WO2014098817A1 (en) 2012-12-19 2012-12-19 Oral care composition

Publications (1)

Publication Number Publication Date
AR094196A1 true AR094196A1 (es) 2015-07-15

Family

ID=47501516

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130104929A AR094196A1 (es) 2012-12-19 2013-12-19 Composicion para el cuidado oral, kit, metodo de fabricacion

Country Status (15)

Country Link
US (1) US9757320B2 (enExample)
EP (1) EP2934440B1 (enExample)
JP (1) JP2016503790A (enExample)
KR (1) KR20150097495A (enExample)
CN (1) CN104853719B (enExample)
AR (1) AR094196A1 (enExample)
AU (1) AU2012397258B2 (enExample)
BR (1) BR112015014447B1 (enExample)
CA (1) CA2892408C (enExample)
IL (1) IL239422A0 (enExample)
MX (1) MX352313B (enExample)
PH (1) PH12015501237A1 (enExample)
RU (1) RU2636218C2 (enExample)
TW (1) TWI532503B (enExample)
WO (1) WO2014098817A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12151007B2 (en) 2020-06-26 2024-11-26 Colgate-Palmolive Company Electrochemical tooth whitening composition and method thereof
JP2024091126A (ja) * 2022-12-23 2024-07-04 サンスター株式会社 ビタミン誘導体含有組成物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63141921A (ja) * 1986-12-04 1988-06-14 Kao Corp 口腔用組成物
US5059416A (en) 1989-06-26 1991-10-22 Warner-Lambert Company Zinc compound delivery system with improved taste and texture
JP3772468B2 (ja) * 1997-06-11 2006-05-10 昭和電工株式会社 L−アスコルビン酸−2−リン酸亜鉛塩及びその製造方法
US6420419B1 (en) * 1997-11-06 2002-07-16 Showa Denko Kabushiki Kaisha L-ascorbic acid 2-phosphate zinc salt and process for manufacturing the same
JP2000351905A (ja) * 1999-04-05 2000-12-19 Showa Denko Kk アスコルビン酸誘導体含有組成物
WO2002058662A2 (en) * 2001-01-24 2002-08-01 Oraceutical Llc Topical oral care compositions
US20040175332A1 (en) 2001-05-10 2004-09-09 Horst Westenfelder Dentrifice
AU2003267393A1 (en) 2002-11-04 2004-06-07 Dsm Ip Assets B.V. Oral care compositions comprising ascorbic acid derivative
ES2374815T3 (es) * 2003-06-16 2012-02-22 Dsm Ip Assets B.V. Composición de alimento para mascotas.
KR20060121866A (ko) * 2003-09-09 2006-11-29 디에스엠 아이피 어셋츠 비.브이. 산화에 민감한 물질 하나 이상을 함유하는 경구 활성을갖는 본질적으로 무수성의 국소 작용제
US20050271602A1 (en) 2004-06-02 2005-12-08 Nebojsa Milanovich Method for inhibiting chemical staining of teeth
LT1791791T (lt) * 2004-09-27 2019-09-10 Special Water Patents B.V. Vandens valymo būdai ir kompozicijos
WO2007099398A2 (en) 2005-09-27 2007-09-07 Naturalite Benelux B.V. Methods and compositions for treatment of skin
US8337818B2 (en) 2004-11-03 2012-12-25 Colgate-Palmolive Company Post-foaming dental mousse and methods utilizing the same
EP1698324A1 (en) * 2004-11-09 2006-09-06 The Procter & Gamble Company Zinc-containing dentifrice compositions having an improved taste
US8858920B2 (en) 2004-12-21 2014-10-14 Colgate-Palmolive Company Anti-caries oral care composition with xylitol
US8758838B2 (en) 2005-08-31 2014-06-24 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and methods of use
CA2752337C (en) 2005-12-21 2017-01-17 Colgate-Palmolive Company Improved oral compositions comprising zinc citrate and/or tocopherol agents
US20110280855A1 (en) 2006-10-23 2011-11-17 Neil Levin Vitamin c compositions
MY155634A (en) 2008-12-24 2015-11-13 Lion Corp Dentifrice composition
BRPI0924882A2 (pt) 2009-04-01 2015-07-07 Colgate Palmolive Co Composição para cuidado oral, e, uso de pelo menos um composto de carbonato e pelo menos um excipiente
TW201110996A (en) 2009-06-03 2011-04-01 Colgate Palmolive Co Borinic compositions
CA2792857A1 (en) 2010-03-17 2011-09-22 Arbonne International Llc Topical skin care composition
US8916139B2 (en) 2010-04-09 2014-12-23 Conopco, Inc. Oral care compositions
BR112013010519A2 (pt) 2010-10-27 2016-07-05 Colgate Palmolive Co composição de higiene oral compreendendo arginina e carbonato de cálcio
JP5716388B2 (ja) * 2010-12-24 2015-05-13 ライオン株式会社 歯磨剤組成物及び歯磨剤組成物におけるアスコルビン酸リン酸エステル又はその塩の安定化方法
EP2694020B1 (en) 2011-04-04 2019-05-08 Unilever PLC Oral care compositions

Also Published As

Publication number Publication date
PH12015501237A1 (en) 2015-08-17
EP2934440A1 (en) 2015-10-28
CN104853719A (zh) 2015-08-19
MX2015007677A (es) 2015-09-07
TW201438750A (zh) 2014-10-16
RU2015129108A (ru) 2017-01-25
BR112015014447A2 (pt) 2017-07-11
TWI532503B (zh) 2016-05-11
AU2012397258A1 (en) 2015-06-11
MX352313B (es) 2017-11-17
CA2892408A1 (en) 2014-06-26
CA2892408C (en) 2019-10-08
US20160008254A1 (en) 2016-01-14
RU2636218C2 (ru) 2017-11-21
KR20150097495A (ko) 2015-08-26
WO2014098817A1 (en) 2014-06-26
BR112015014447B1 (pt) 2019-07-09
US9757320B2 (en) 2017-09-12
JP2016503790A (ja) 2016-02-08
CN104853719B (zh) 2017-11-03
EP2934440B1 (en) 2018-02-21
IL239422A0 (en) 2015-07-30
AU2012397258B2 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
CL2019001079A1 (es) Métodos para usar indazol-3-carboxamidas y su uso como inhibidores de la vía de señalización de wnt/b-catenina.
ES2573524T3 (es) Nuevo principio activo anti-enrojecimiento y composiciones cosméticas que lo comprenden
ECSP19043725A (es) Composiciones de aminoácidos y métodos para el tratamiento de enfermedades y trastornos musculares
WO2015085143A3 (en) Therapeutic agents for skin diseases and conditions
BR112015027282A2 (pt) fenfluramina para uso no tratamento de síndrome de dravet
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
DOP2012000299A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
CL2017003066A1 (es) Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal
BR112015007814A2 (pt) diagnóstico, prevenção e tratamento de doenças da articulação
BR112014015482A2 (pt) compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática
MX347927B (es) Vitamina c y vitamina k libre de cromo, y composiciones de estas para tratar un estado o enfermedad en las que interviene nfkb.
BR112014010376A2 (pt) medicamento para o tratamento de doença do olho anterior que compreende rebamipida e um agente de retenção de lágrima
AR096854A1 (es) Composición farmacéutica para una liberación sostenida de lanreotide
CA2986891C (en) Compositions for use in treating parkinson's disease and related disorders
CO2017003263A2 (es) Composición farmacéutica basadas en anamorelina que tienen actividad sobre caquexia causada por cáncer
CO7101244A2 (es) Fenilimidazopirazoles sustituidos y su uso
BR112015030087A2 (pt) composição compreendendo ácido láctico tamponado
MX372875B (es) Composiciones para el cuidado bucal que comprenden al menos un copolímero de fosfato / acrilato y al menos un ingrediente activo catiónico.
BR112014031706A2 (pt) composição farmacêutica oral; forma de composição farmacêutica oral; método de redução de efeito de alimento de itraconazol em um indivíduo; método de redução de variabilidade em um mesmo indivíduo de itraconazol; método de redução de variabilidade entre indivíduos de itraconazol; método de tratamento de onicomicose; método de tratamento de uma doença ou afecção e método de tratamento de câncer
MX2018011539A (es) Tratamiento de dolencias y enfermedades cutaneas asociadas a biopeliculas microbianas.
WO2014142760A3 (en) Re-trafficking of herg reverses long qt syndrome 2 phenotype in human ips-derived cardiomyocytes
BR112015027992A2 (pt) uso de ácido petroselínico para combater desordens estéticas da figura do corpo
IL250852B (en) Periodontal preparation
BR112013026933A2 (pt) uso de uma combinação de pelo menos um carotenoide
MX2018002298A (es) Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure